BioAge prices $115 million upsized public offering at $19.50 per share Jan 21, 2026 10:30PM
BioAge Announces Pricing of Upsized $115.0 Million Public Offering Jan 21, 2026 10:30PM
BioAge plans $75 million public stock offering to fund drug development Jan 20, 2026 04:01PM
BioAge Announces Proposed Public Offering Jan 20, 2026 04:01PM
Citi Upgrades BioAge Labs Inc (BIOA) to Buy Oct 22, 2025 05:02AM


Aug 20, 2025 04:30PM BioAge Labs to Present at Upcoming Investor Conferences
Dec 9, 2024 05:01AM Citi Downgrades BioAge Labs Inc (BIOA) to Neutral
Nov 21, 2024 04:30PM BioAge Labs to Present at Upcoming Investor Conferences
Oct 21, 2024 07:26AM Citi Starts BioAge Labs Inc (BIOA) at Buy
Oct 1, 2024 04:30PM BioAge Labs Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares and Closing of the Concurrent Private Placement
Sep 26, 2024 06:03AM BioAge Labs (BIOA) Announces Upsized 11M Share Offering at $18/sh
Sep 25, 2024 08:00PM BioAge Labs Announces Pricing of Upsized Initial Public Offering
Sep 3, 2024 04:05PM BioAge Labs (BIOA) Files for Proposed IPO